Paul Tappenden1, J Jaime Caro2,3,4. 1. HEDS, ScHARR, University of Sheffield, Sheffield, UK. 2. Department of Health Policy, The London School of Economics and Political Science, London, UK. Jaime.caro@mcgill.ca. 3. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada. Jaime.caro@mcgill.ca. 4. Evidera, Waltham, MA, USA. Jaime.caro@mcgill.ca.
Authors: Ash Bullement; Matthew Taylor; Sam Thomas McMordie; Errol Waters; Anthony James Hatswell Journal: Pharmacoeconomics Date: 2019-11 Impact factor: 4.981
Authors: Christopher James Sampson; Renée Arnold; Stirling Bryan; Philip Clarke; Sean Ekins; Anthony Hatswell; Neil Hawkins; Sue Langham; Deborah Marshall; Mohsen Sadatsafavi; Will Sullivan; Edward C F Wilson; Tim Wrightson Journal: Pharmacoeconomics Date: 2019-11 Impact factor: 4.981
Authors: Fernando Alarid-Escudero; Eline M Krijkamp; Petros Pechlivanoglou; Hawre Jalal; Szu-Yu Zoe Kao; Alan Yang; Eva A Enns Journal: Pharmacoeconomics Date: 2019-11 Impact factor: 4.981
Authors: Nasuh C Büyükkaramikli; Maureen P M H Rutten-van Mölken; Johan L Severens; Maiwenn Al Journal: Pharmacoeconomics Date: 2019-11 Impact factor: 4.981
Authors: Josh J Carlson; Surrey M Walton; Anirban Basu; Richard H Chapman; Jonathan D Campbell; R Brett McQueen; Steven D Pearson; Daniel R Touchette; David Veenstra; Melanie D Whittington; Daniel A Ollendorf Journal: Pharmacoeconomics Date: 2019-11 Impact factor: 4.981
Authors: Seamus Kent; Frauke Becker; Talitha Feenstra; An Tran-Duy; Iryna Schlackow; Michelle Tew; Ping Zhang; Wen Ye; Shi Lizheng; William Herman; Phil McEwan; Wendelin Schramm; Alastair Gray; Jose Leal; Mark Lamotte; Michael Willis; Andrew J Palmer; Philip Clarke Journal: Pharmacoeconomics Date: 2019-11 Impact factor: 4.981